New Study Highlights Depixus’ Scalable Platform for Accelerating RNA-Targeted Drug Development

A study published in Nature Communications showcases how Depixus’ scalable single molecule technology offers detailed insights into RNA-ligand interactions, aiding the development of new therapeutics. Using magnetic force spectroscopy (MFS), Depixus’ platform is the first of its kind to analyze…

Read MoreNew Study Highlights Depixus’ Scalable Platform for Accelerating RNA-Targeted Drug Development

Fathom Achieves 100% Customer Satisfaction and 90%+ Coding Automation in KLAS Report

Fathom, a leader in autonomous medical coding, announced today that its technology received 100% high customer satisfaction and unanimous validation of its 90%+ automation rates in a recent KLAS Research Emerging Company Spotlight report. KLAS, a leading healthcare technology analyst,…

Read MoreFathom Achieves 100% Customer Satisfaction and 90%+ Coding Automation in KLAS Report

GE Appliances Partners with Mothers’ Milk Bank Northeast to Support Families with Innovative Technology

GE Appliances, a leading home appliance manufacturer, has announced a significant partnership with Mothers’ Milk Bank Northeast, a nonprofit dedicated to supplying lifesaving pasteurized donor human milk to premature and medically fragile babies. This collaboration aims to transform the tracking…

Read MoreGE Appliances Partners with Mothers’ Milk Bank Northeast to Support Families with Innovative Technology

LEO Pharma Unveils Anzupgo® (delgocitinib) Cream Results at EADV 2024 for Chronic Hand Eczema

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data from the DELTA FORCE trial at the 33rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam. The company shared six additional abstracts regarding Anzupgo® (delgocitinib)…

Read MoreLEO Pharma Unveils Anzupgo® (delgocitinib) Cream Results at EADV 2024 for Chronic Hand Eczema

Perosphere Technologies to Present on Point-of-Care Coagulometer at ADLM CPOCT Symposium

Perosphere Technologies Inc., a private medical tech company specializing in next-generation coagulation diagnostics, announced its participation in the 29th ADLM International Critical & Point of Care Testing (CPOCT) Symposium, held September 25-27, 2024, in San Diego, CA. Perosphere CEO Dr.…

Read MorePerosphere Technologies to Present on Point-of-Care Coagulometer at ADLM CPOCT Symposium

C2N Secures Funding to Develop Decentralized Mass Spectrometry for Global Alzheimer’s Testing

C2N Diagnostics, a global leader in Alzheimer’s diagnostics with its Precivity blood tests, plans to develop a fully automated and standardized high-resolution LC-MS platform. This technology will allow local clinical labs worldwide to utilize the precise innovation behind C2N’s clinical…

Read MoreC2N Secures Funding to Develop Decentralized Mass Spectrometry for Global Alzheimer’s Testing